Untitled - Roche Trasplantes

DIAGNÓSTICO PRECOZ DEL RECHAZO SUBCLÍNICO MEDIANTE BIOPSIAS
DE PROTOCOLO
35. Moreso F, Ibernon M, Goma M y cols. Subclinical rejection associated with chronic
allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J
Transplant 2006; 6: 747-52.
36. Moreso F, Serón D, Gil-Vernet S y cols. Donor age and delayed graft function as predictors
of renal allograft survival in rejection-free patients. Nephrol Dial Transplant
1999; 14: 930-5.
37. Nankivell BJ, Borrows RJ, Fung CLS, O’Connell PO, Allen RDM, Chapman JR. The
natural history of chronic allograft nephropathy. N Eng J Med 2003; 349: 2326-33.
38. Ibernon M, Goma M, Moreso F y cols. Subclinical rejection impairs glomerular adaptation
after renal transplantation. Kidney Int 2006 (en prensa).
39. Bonsib SM, Abul-Ezz SR, Ahmad I y cols. Acute rejection-associated tubular basement
membrane defects and chronic allograft nephropathy. Kidney Int 2000; 58: 2206-14.
40. Rush DN, Nickerson P, Gough J y cols. Beneficial effects of treatment of early subclinical
rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129-34.
41. Nickerson P, Jeffery J, Gough J y cols. Effect of increasing baseline immunosuppression
on the prevalence of subclinical rejection: a pilot study. J Am Soc Nephrol
1999; 10: 1801-5.
42. Moreso F, Serón D, Carrera M y cols. Baseline immunosuppresion is associated with
histological findings in early protocol biopsies. Transplantation 2004; 78: 1064-8.
43. Gloor JM, Cohen AJ, Lager DJ y cols. Subclinical rejection in tacrolimus-treated renal
transplant patients. Transplantation 2002; 1965-8.
44. Barama A, Sepandj F, Gough J, McKenna R. Correlation between Neoral 2 hours postdose
and histologic findings on surveillance biopsies. Transplant Proc 2004; 36 (Suppl.
2): 465S-467S.
45. Anil Kumar MS, Heifets M, Fyfe B y cols. Comparison of steroid avoidance in tacrolimus/mycophenolate
mofetil and tacrolimus/sirolimus combination in kidney transplantation
monitored by surveillance biopsies. Transplantation 2005; 80: 807-14.
46. Buehrig CK, Lager DJ, Stegall MD y cols. Influence of surveillance renal allograft biopsy
on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003;
64: 665-73.
47. Shishido S, Asanuma H, Nakai H y cols. The impact of repeated subclinical acute rejection
on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003;
14: 1046-52.
48. Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent
decline in kidney allograft function from early surveillance biopsies. Am J
Transplant 2005; 5: 2464-72.
49